Sarepta Therapeutics Inc

General ticker "SRPT" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $12.0B

Sarepta Therapeutics Inc follows the US Stock Market performance with the rate: 15.4%.

Estimated limits based on current volatility of 1.4%: low 118.77$, high 122.09$

Factors to consider:

  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [64.46$, 130.46$]
  • 2024-12-30 to 2025-12-30 estimated range: [51.29$, 107.59$]

Financial Metrics affecting the SRPT estimates:

  • Negative: Non-GAAP EPS, $ of -1.23 <= 0.10
  • Negative: Operating profit margin, % of -17.72 <= 1.03
  • Negative: Operating cash flow per share per price, % of -5.76 <= 2.35
  • Negative: negative Net income
  • Positive: -3.48 < Investing cash flow per share, $ of -1.79

Similar symbols

Short-term SRPT quotes

Long-term SRPT plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $701.89MM $933.01MM $1,243.34MM
Operating Expenses $1,151.60MM $1,469.21MM $1,511.16MM
Operating Income $-449.71MM $-536.20MM $-267.82MM
Non-Operating Income $30.76MM $-153.76MM $-252.27MM
Interest Expense $63.52MM $53.25MM $22.01MM
R&D Expense $771.18MM $877.09MM $877.39MM
Income(Loss) $-418.95MM $-689.96MM $-520.10MM
Taxes $-0.17MM $13.53MM $15.88MM
Profit(Loss) $-418.78MM $-703.49MM $-535.98MM
Stockholders Equity $928.01MM $384.95MM $859.34MM
Inventory $186.21MM $203.97MM $322.86MM
Assets $3,147.97MM $3,128.37MM $3,264.58MM
Operating Cash Flow $-443.17MM $-325.35MM $-500.99MM
Capital expenditure $38.49MM $30.82MM $76.11MM
Investing Cash Flow $495.41MM $-1,046.88MM $-165.80MM
Financing Cash Flow $561.57MM $232.51MM $125.00MM
Earnings Per Share* $-5.15 $-8.03 $-5.80

* EPS are Split Adjusted, recent splits may be reflected with a delay.